Comienzos
keyboard_arrow_right
keyboard_arrow_right
Online Physician Portals Evolve into Clinical Resources.
Nutrition

Online Physician Portals Evolve into Clinical Resources.

One notable exception of a site that offers transcended the country divides offers been the Univadis portal from MSD . For a long time, Univadis was the leading portal for physicians across Europe by giving content created specifically for the individual nation, in said country’s vocabulary. The success of Univadis hasn’t gone unnoticed, and pan-European content resources for physicians are constantly emerging and attaining traction among European physicians. New examples continue to emerge. WebMD lately announced a partnership with Medcenter to offer its Medscape content material to physicians in Spain and in Portugal while United Business Media’s SearchMedica continues to expand its offerings in a range of specialties and languages.

ARIAD reports $159.3 million second-quarter net income ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and half a year ended June 30, 2013 and provided an revise on corporate advancements. Berger, M.D., chairman and ceo of ARIAD. We are on the right track to achieve these goals also to travel and retain essential shareholder worth for our pipeline items. Financial Highlights For the quarter ended June 30, 2013, the business reported net gain of $159.3 million, or $1.35 per share on a diluted basis, compared to a net lack of $21.0 million, or $0.24 per share, for the same period in 2009 2009. For the six-month period ended June 30, 2013, the Company reported net income of $136.0 million, or $1.22 per talk about on a diluted basis, in comparison to a net loss of $41.2 million, or $0.50 per share for the same period in ’09 2009.ARIAD reports $159.3 million second-quarter net income ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and half a year ended June 30, 2013 and provided an revise on corporate advancements. Berger, M.D., chairman and ceo of ARIAD. We are on the right track to achieve these goals also to travel and retain essential shareholder worth for our pipeline items. Financial Highlights For the quarter ended June 30, 2013, the business reported net gain of $159.3 million, or $1.35 per share on a diluted basis, compared to a net lack of $21.0 million, or $0.24 per share, for the same period in 2009 2009. For the six-month period ended June 30, 2013, the Company reported net income of $136.0 million, or $1.22 per talk about on a diluted basis, in comparison to a net loss of $41.2 million, or $0.50 per share for the same period in ’09 2009.